Abstract:Motivation: Cancer is a complex disease that involves rapidly evolving cells, often forming multiple distinct clones. In order to effectively understand progression of a patient-specific tumor, one needs to comprehensively sample tumor DNA at multiple time points, ideally obtained through inexpensive and minimally invasive techniques. Current sequencing technologies make the 'liquid biopsy' possible, which involves sampling a patient's blood or urine and sequencing the circulating cell free DNA (cfDNA). A certain percentage of this DNA originates from the tumor, known as circulating tumor DNA (ctDNA). The ratio of ctDNA may be extremely low in the sample, and the ctDNA may originate from multiple tumors or clones. These factors present unique challenges for applying existing tools and workflows to the analysis of ctDNA, especially in the detection of structural variations which rely on sufficient read coverage to be detectable. Results: Here we introduce SViCT , a structural variation (SV) detection tool designed to handle the challenges associated with cfDNA analysis. SViCT can detect breakpoints and sequences of various structural variations including deletions, insertions, inversions, duplications and translocations. SViCT extracts discordant read pairs, one-end anchors and soft-clipped/split reads, assembles them into contigs, and re-maps contig intervals to a reference genome using an efficient k-mer indexing approach. The intervals are then joined using a combination of graph and greedy algorithms to identify specific structural variant signatures. We assessed the performance of SViCT and compared it to state-of-the-art tools using simulated cfDNA datasets with properties matching those of real cfDNA samples. The positive predictive value and sensitivity of our tool was superior to all the tested tools and reasonable performance was maintained down to the lowest dilution of 0.01% tumor DNA in simulated datasets. Additionally, SViCT was able to detect all known SVs in two real cfDNA reference datasets (at 0.6-5% ctDNA) and predict a novel structural variant in a prostate cancer cohort. Availability: SViCT is available at https://github.com/vpc-ccg/svict. Contact:faraz.hach@ubc.ca.

Structural variation and its mechanism detection based on clustering algorithm

Structural Variation Detection Algorithm in High-throughput Sequencing Data

Integrative detection and analysis of structural variation in cancer genomes

Detecting Structural Variations in the Human Genome Using Next Generation Sequencing

Structural Variations of the 3D Genome Architecture in Cervical Cancer Development

Diverse Mechanisms of Somatic Structural Variations in Human Cancer Genomes

An Integrative Framework for Detecting Structural Variations in Cancer Genomes

Chromosome Structural Variation in Tumorigenesis: Mechanisms of Formation and Carcinogenesis.

Detection of Common Copy Number Variation with Application to Population Clustering from Next Generation Sequencing Data.

Overview of structural variation calling: Simulation, identification, and visualization

Identification of structural variation in mouse genomes

Rapid Detection of Structural Variation in a Human Genome Using Nanochannel-Based Genome Mapping Technology.

Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA

Patterns of somatic structural variation in human cancer genomes

Mapping and sequencing of structural variation from eight human genomes

Detection of Structural Variations and Fusion Genes in Breast Cancer Samples Using Third-Generation Sequencing

Global Impact of Somatic Structural Variation on the DNA Methylome of Human Cancers

An Integrated Map of Structural Variation in 2,504 Human Genomes.

Analysis of Hi-C Data for Discovery of Structural Variations in Cancer.

Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies

[Copy Number Variations in the Human Genome: Their Mutational Mechanisms and Roles in Diseases].